Drug Approval | April 20, 2023
Zydus receives final approval from USFDA for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted
Ayurveda OPD will be established in 10 ECHS Polyclinic/Dispensaries in various regions of India to cover all ECHS members on a voluntary basis
eSanjeevani 2.0 will enhance the telemedicine experience further with a plethora of new features both in terms of technology as well as innovation
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
Global pharmaceutical company having a surgical business concept incepted in Dubai
Subscribe To Our Newsletter & Stay Updated
